Block Biosciences: Funding, Investors & Team (Sep 2026)
Block Biosciences is a life‑sciences startup that develops small‑molecule therapeutics aimed at blocking the spread of cancer to the brain. The company works on inhibiting specific metabolic pathways that cancer cells use to initiate brain metastases, using predictive models and targeted drug design. It also explores companion‑diagnostic‑type tools to help identify patients at high risk for brain spread.
Block Biosciences has raised $70k across 1 funding round on record, the most recent a Seed of $70k announced in Mar 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Block Biosciences Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Block Biosciences Funding Rounds
Block Biosciences Founders and Leadership Team
Contact details for the Block Biosciences team: 1 has a LinkedIn profile.
Start 14-day free trial →Block Biosciences Funding Compared to Other Biotechnology Startups
Block Biosciences' latest round of $70k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Block Biosciences in Biotechnology and Hamilton
Companies Similar to Block Biosciences
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Block Biosciences Funding FAQs
What does Block Biosciences do?
Block Biosciences is a life‑sciences startup that develops small‑molecule therapeutics aimed at blocking the spread of cancer to the brain. The company works on inhibiting specific metabolic pathways that cancer cells use to initiate brain metastases, using predictive models and targeted drug design. It also explores companion‑diagnostic‑type tools to help identify patients at high risk for brain spread.
How much funding has Block Biosciences raised?
Block Biosciences has raised $70k across 1 round on record. The most recent is a Seed of $70k announced in Mar 2026.
When did Block Biosciences last raise funding?
Block Biosciences' most recent funding round on record is a Seed of $70k, announced in Mar 2026.
Who founded Block Biosciences?
FundedIQ lists Agata Kieliszek (Founder) at Block Biosciences.
Where is Block Biosciences headquartered?
Block Biosciences is based in Hamilton, Ontario, Canada.
How many employees does Block Biosciences have?
Block Biosciences is in the 1-10 employee band.
How does Block Biosciences' funding compare to other Biotechnology startups?
Block Biosciences' latest round of $70k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Block Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Block Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.